RetigabineRetigabine (INN) or ezogabine (USAN) is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Read from the Drugbox of the Wikipedia article Retigabine, revision 1364201705.

Property

Value

Formula

C16H18FN3O2, 303.34 g/mol

Bioavailability

60 %

Protein binding

70 %

Elimination half-life

8 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.